Shanghai Titan Scientific financials at a glance
| Year | Year | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥1.38B | ¥2.18B | ¥2.61B | ¥2.77B | ¥0.00M |
| GM % | Gross Margin % |
|
21.14% | 7.96% | 21.61% | 3.12% | 0.00% |
| OM | Operating Margin |
|
7.93% | 7.96% | 5.93% | 3.12% | 0.00% |
| EPS | Earnings Per Share |
|
¥0.99 | ¥0.44 | ¥0.00 | ||
| Div. | Dividends |
|
¥0.00 | ¥0.00 | ¥0.14 | ¥0.10 | ¥0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 14.14% | 22.73% | 0 |
| Sha. | Shares |
|
76.25m | 76.25m | 76.25m | 0m | 117.97m |
| OCF | Operating Cash Flow |
|
¥-138.16M | ¥-242.22M | ¥-151.39M | ¥0.00M | ¥0.00M |
| FCF | Free Cash Flow |
|
¥-234.72M | ¥-377.43M | ¥-450.97M | ¥0.00M | ¥0.00M |
| FCFS | Free Cash Flow Per Share |
|
¥-2.77 | ¥-3.54 | ¥-4.08 | ¥0.00 | ¥0.00 |